Regeneron Pharmaceuticals, Inc.

New England Research & Management, Inc. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/7/2026

Shares

500

Value ($000)

386

Weight

0.2%

2013 Q4 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/7/2026	386	0.2%	500	12/31/2025
2025 Q2	7/9/2025	318	0.2%	605	6/30/2025
2013 Q4	1/8/2014	688	0.7%	2,498	12/31/2013